| scholarly article | Q13442814 |
| P5530 | Altmetric DOI | 10.1017/JNS.2015.18 |
| P6179 | Dimensions Publication ID | 1039092531 |
| P356 | DOI | 10.1017/JNS.2015.18 |
| P953 | full work available at URL | http://eprints.whiterose.ac.uk/91122/ |
| https://doi.org/10.1017/jns.2015.18 | ||
| P932 | PMC publication ID | 4611081 |
| P698 | PubMed publication ID | 26495120 |
| P5875 | ResearchGate publication ID | 283176765 |
| P1154 | Scopus EID | 2-s2.0-84994627723 |
| P2093 | author name string | Kevin Williamson | |
| Nicola Clibbens | |||
| Karen Kilner | |||
| P2860 | cites work | Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis | Q22241292 |
| A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women | Q33904166 | ||
| Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London | Q33911053 | ||
| Vitamin D deficiency and psychotic features in mentally ill adolescents: a cross-sectional study | Q34263682 | ||
| Serum 25-hydroxyvitamin D3 and D2 and non-clinical psychotic experiences in childhood | Q34358624 | ||
| The dietary pattern of patients with schizophrenia: a systematic review | Q34478679 | ||
| Selenium intake, mood and other aspects of psychological functioning | Q35037314 | ||
| Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. | Q35090012 | ||
| Homocysteine, folate, methylation, and monoamine metabolism in depression | Q35458595 | ||
| Sugars, hypertriglyceridemia, and cardiovascular disease | Q35548930 | ||
| Mechanisms of neuroprotective action of vitamin D(3). | Q35862617 | ||
| Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis | Q36178681 | ||
| Schizophrenia, social class and immigrant status: the epidemiological evidence. | Q36299679 | ||
| Plasma total antioxidant status and cognitive impairments in schizophrenia. | Q50955815 | ||
| Physical activity, dietary habits and Coronary Heart Disease risk factor knowledge amongst people with severe mental illness: a cross sectional comparative study in primary care. | Q51900120 | ||
| Physical illness and lifestyle risk factors in people with their first presentation of psychosis. | Q51908617 | ||
| P.4.011 The role of stress and inflammation in diet and metabolic status in first-episode psychosis | Q58324179 | ||
| Vitamin D in schizophrenia, major depression and alcoholism | Q61908143 | ||
| Dietary reference values for food energy and nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy | Q68074301 | ||
| The unhealthy lifestyle of people with schizophrenia | Q77998173 | ||
| Schizophrenia and increased risks of cardiovascular disease | Q36336286 | ||
| The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers | Q36864458 | ||
| Managing weight gain and metabolic issues in patients treated with atypical antipsychotics. | Q37117762 | ||
| Drug-induced hyperphagia: what can we learn from psychiatric medications? | Q37254782 | ||
| The methylation, neurotransmitter, and antioxidant connections between folate and depression | Q37307834 | ||
| Time use among people with psychiatric disabilities: implications for practice | Q37366201 | ||
| Diagnosis and management of vitamin D deficiency. | Q37671973 | ||
| Metabolic syndrome with the atypical antipsychotics | Q37780660 | ||
| Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions. | Q37872619 | ||
| Vitamin D and the brain. | Q37923122 | ||
| The psychobiology of comfort eating: implications for neuropharmacological interventions | Q38031343 | ||
| Anxiety as a core aspect of schizophrenia | Q38093455 | ||
| Dietary habits of patients with schizophrenia: a self-reported questionnaire survey. | Q39624970 | ||
| Dietary intake profile of patients with schizophrenia. | Q39757707 | ||
| The relationship between stress, dietary restraint, and food preferences in women | Q40011242 | ||
| The cardiovascular and respiratory health of people with schizophrenia | Q40330946 | ||
| Body mass index and future schizophrenia in Israeli male adolescents. | Q40466734 | ||
| Free radical involvement in neuropsychiatric illnesses | Q40483246 | ||
| The paradox of premature mortality in schizophrenia: new research questions | Q42412750 | ||
| Oxidative stress in schizophrenia: pathogenetic and therapeutic implications | Q42872138 | ||
| Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia | Q44299748 | ||
| Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human | Q44448583 | ||
| Nutritional assessment of patients with schizophrenia: a preliminary study | Q44613832 | ||
| Skeletal Status in Psychotic Disorders: A Population-Based Study | Q44620562 | ||
| The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia | Q44766600 | ||
| Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial | Q44861962 | ||
| An animal model of antipsychotic-induced weight gain | Q44890737 | ||
| Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms | Q45245434 | ||
| Socio-economic disparities in the consumption of vegetables, fruit and energy-dense foods: the role of motive priorities. | Q45992058 | ||
| Acute effects of olanzapine on behavioural expression including the behavioural satiety sequence in female rats | Q46070377 | ||
| The role of thermogenesis in antipsychotic drug-induced weight gain. | Q46184209 | ||
| Antipsychotic drug-induced weight gain: development of an animal model | Q46408562 | ||
| Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats | Q46587038 | ||
| Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities. | Q47316994 | ||
| Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis. | Q47421031 | ||
| Income-related inequality in mental health in Britain: the concentration index approach. | Q50182775 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | psychosis | Q170082 |
| nutrient intake | Q61781968 | ||
| P304 | page(s) | e28 | |
| P577 | publication date | 2015-08-20 | |
| P1433 | published in | Journal of nutritional science | Q27724435 |
| P1476 | title | A comparison of the nutrient intake of a community-dwelling first-episode psychosis cohort, aged 19-64 years, with data from the UK population | |
| P478 | volume | 4 |
| Q47567371 | Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis | cites work | P2860 |
Search more.